Crystal structure of a hydrophobic immunodominant antigenic site on hepatitis C virus core protein complexed to monoclonal antibody 19D9D6

Journal of Immunology

Volumn 170, Issue 4, 2003, Pages 1917-1924

  Ménez, Renée ^a   Bossus, Marc ^a   Muller, Bruno H ^a   Sibaï, Geneviève ^b   Dalbon, Pascal ^b   Ducancel, Frédéric ^a   Jolivet Reynaud, Colette ^b,c   Stura, Enrico A ^a  

^a DIF   (France)

^b BIOMÉRIEUX   (France)

^c Ctr d'Etudes de Rech en Virologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 19D9D6; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; HEPATITIS C VIRUS; HUMAN; HYDROPHOBICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE;

EID: 0037442111     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.4.1917     Document Type: Article

References (42)

1. Choo, Q.-L., G. Kuo, A. J. Weiner, L. R., Overby, L. R. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone from a blood-borne non-A, non-B viral hepatitis C virus. Science 244:359.
2. Houghton, M., A. Weiner, J. Han, G. Kuo, and Q.-L. Choo. 1991. Molecular biology of the hepatitis C virus: implications for diagnosis, development, and control of viral disease. Hepatology 14:381.
3. Park, H. J., S.-M. Byun, Y. J. Ha, J. S. Ahn, and H. M. Moo. 1995. Identification of immunodominant epitopes in the core and non-structural region of hepatitis C virus by enzyme immunoassay using synthetic peptides. J. Immunoassay 16:167.
4. Dickson, R. C., M. Mizokami, E. Orito, K. Qian, and J. Y. Lau. 1999. Quantification of serum HCV core antigen by a fluorescent enzyme immunoassay in liver transplant recipients with recurrent hepatitis C: clinical and virologic implications. Transplantation 68:1512.
5. Tanaka, E., C. Ohue, K. Aoyagi, K. Yamaguchi, S. Yagi, K. Kiyosawa, and H. J. Alter. 2000. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology 32:388.
6. McLauchlan, J. 2000. Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J. Viral Hepatitis 7:2.
7. Sabile, A., G. Perlemuter, F. Bono, K. Kohara, F. Demaugre, M. Kohara, Y. Matsuura, T. Miyamura, C. Brechot, and G. Barba. 1999. Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology 30:1064.
8. Wong, D. K., D. D. Dudley, N. H. Afdhal, J. Dienstag, C. M. Rice, L. Wang, M. Houghton, B. D. Walker, and M. J. Koziel. 1998. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J. Immunol. 160:1479.
9. Jolivet-Reynaud, C., P. Dalbon, F. Viola, S. Yvon, G. Paranhos-Baccala, N. Piga, L. Bridon, M. A. Trabaud, N. Battail, G. Sibai, et al. 1998. HCV core immuno-dominant region analysis using mouse monoclonal antibodies and human sera: characterization of major epitopes useful for antigen detection. J. Med. Virol. 56:300.
10. Cerino, A., P. Boender, N. La Monica, C. Rosa, W. Habets, and M. U. Mondelli. 1993. A human monoclonal antibody specific for the N terminus of the hepatitis C virus core protein. J. Immunol. 151:7005.
11. Siemoneit, K., M. da Silva Cardoso, A. Wölpl, K. Koerner, and B. Subanek. 1994. Isolation and epitope characterization of human monoclonal antibodies to hepatitis C virus core antigen. Hybridoma 13:9.
12. Barban, V., S. Fraysse-Corgier, G. Paranhos-Baccala, M. Petit, C. Manin, Y. Berard, A. M. Prince, B. Mandrand, and P. Meulien. 2000. Identification of a human epitope in hepatitis C virus (HCV) core protein using a molecularly cloned antibody repertoire from non-symptomatic, anti-HCV-positive patient. J. Gen. Virol. 81:461.
13. Buratti, E., M. Di Michele, P., Song, C. Monti-Bragadin, E. A. Scodeller. F. E. Baralle, and S. G. Tisminetzky. 1997. Improved reactivity of hepatitis C virus core protein epitopes in conformational antigen-presenting system. Clin. Diagn. Lab. Immunol. 4:117.
14. F. Penin, L. Ladavière, P. Dalbon, X. Lacoux, G. Deldage, and M. Jolivet. 1997. Three dimensional structure analysis of the immuno-dominant antigenic domain of the HCV nucleocapsid by 1H-NMR. In Proceedings of the 4th International Meeting on Hepatitis C Virus and Related Viruses. March 6-10, 1997. Kyoto, Japan, p. 10.
15. Jolivet, M., F. Penin, P. Dalbon, L., Ladavière, and X. Lacoux. 1997. Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an HCV infection. Patent application EP 1015481. WO 98/39360.
16. Stura, E. A. 2001. A simple modification of the Q-plate for parallel screening and combinatorial crystallization. J. Cryst. Growth 232:545.
17. Stura. E. A. 1999. Strategy 3: reverse screening. In Crystallization of Proteins: Techniques, Strategies and Tips: A Laboratory manual. T. Bergfors, ed. International University Line, La Jolla, p. 113.
18. Graille, M., E. A. Stura, N. G. Housden, J. A. Beckingham, S. P. Bottomley, D. Beale, M. J. Taussig, B. J. Sutton, M. G. Gore, and J.-B. Charbonnier. 2001. Complex between Peptostreptococcus magnus protein L and a human antibody reveals structural convergence in the interaction modes of Fab binding proteins. Structure 9:679.
19. Monnet, C., F. Bettsworth, E. A. Stura, M. H. Le Du, R. Menez, L. Derrien, S. Zinn-Justin, B. Gilquin, G. Sibai, N. Battail-Poirot, et al. 2002. Highly specific anti-estradiol antibodies: structural characterization and binding diversity. J. Mol. Biol. 315:699.
20. Stura, E. A., M. Graille, N. G. Housden, and M. G. Gore. 2002. Protein L mutants for the crystallization of antibody fragments. Acta Crystallogr. D Biol. Crystallogr. 58:1744.
21. Karray, S., and M. Zouali. 1997. Identification of the B cell superantigen-binding site of HIV-1 gp120. Proc. Natl. Acad. Sci. USA 94:1356.
22. Stura, E. A., L. Martin, H. Lortat-Jacob, R. Vivès, and C. Vita. 2002. Heparin-aggregated RANTES can be crystallised. Acta Crystallogr. D Biol. Crystallogr. 58:1670.
23. Stura, E. A. 1999. Seeding techniques. In Crystallization of Nucleic Acids and Proteins: A Practical Approach, 2nd Ed. A. Ducruix and R. Giegé, eds. Oxford University Press, Oxford, p. 177.
24. Otwinowski, Z., and W. Minor. 1997. Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307.
25. Matthews, B. W. 1968. Solvent content of protein crystals. J. Mol. Biol. 33:491.
26. Graille, M., N. G. Housden, S. Harrison, I. S. C. Findlow, M. P. Crump, B. H. Muller, N. Battail-Poirot, G. Sibaï, M. J. Taussig, C. Jolivet-Reynaud, et al. Evidences for plasticity and structural mimicry at the immunoglobulin light chain-protein L interface. J. Biol. Chem. 277:47500.
27. Sheriff, S., C. Y. Chang, P. D. Jeffrey, and J. Bajorath. 1996. X-ray structure of the uncomplexed anti-tumor antibody BR96 and comparison with its antigen-bound form. J. Mol. Biol. 259:938.
28. Navaza, J. 1994. AMoRe: an automated package for molecular replacement. Acta Crystallogr. A 50:157.
29. Arevalo J. H., E. A. Stura, M. J. Taussig, and I. A. Wilson. 1993. Three-dimensional structure of an anti-steroid Fab′ and progesterone Fab′ complex. J. Mol. Biol. 231:103.
30. Rini, J. M., U. Schulze-Gahmen, and I. A. Wilson. 1992. Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science 255:959.
31. Brünger, A. T., P. D. Adams, G. M. Clore, W. L. DeLano, P. Gros, R. W. Grosse-Kunstleve, J.-S. Jiang, J. Kuszewski, M. Nilges, N. S. Pannu, et al. 1998. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54:905.
32. McRee, D. E. 1999. XtalView/Xfit: a versatile program for manipulating atomic coordinates and electron density. J. Struct. Biol. 125:156.
33. Roussel, A., and C. Cambillau. 1989. Silicon Graphics Geometry Partner Directory. Silicon Graphics, Mountain View, pp. 77-78.
34. Laskowsky, R. A., M. W. MacArthur, D. S. Moss, and J. M. Thornton. 1993. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:283.
35. Chothia, C. 1976. The nature of the accessible and buried surfaces in proteins. J. Mol. Biol. 105:1.
36. Janin, J. 1979. Surface and inside volumes in globular proteins. Nature 277:49.1.
37. Ramakrishnan, C., and G. N. Ramachandran. 1965. Allowed conformations for a pair of peptide units. Biophys. J. 5:909.
38. Kabat, E. A., and T. T. Wu. 1991. Attempts to locate complementarity determining residues in the variable positions of light and heavy chains. Ann. NY Acad. Sci. 190:382.
39. Barbey-Martin C., B. Gigant, T. Bizebard, L. J. Calder, S. A. Wharton, J. J. Skehel, and M. Knossow. 2002. An antibody that prevents the hemagglutinin low pH fusogenic transition. Virology 294:70.
40. Stanfield, R. L., and I. A. Wilson. 1995. Protein-peptide interactions. Curr. Opin. Struct. Biol. 5:103.
41. Hope, R. G., and J. McLauchlan. 2000. Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein. J. Gen. Virol. 81:1913.
42. André, P., F. Komurian-Pradel, S. Deforges, M. Perret, J. L. Berland, M. Sodoyer, S. Pol, C. Bréchot, G. Paranhos-Baccalà, and V. Lotteau. 2002. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J. Virol. 76:6919.